Summary:
In this research study, doctors want to test the safety and effectiveness of the study drug for the acute treatment of migraine.
Length of study: up to 11 weeks
Number of office visits: up to 3 visits
Qualified Participants Must:
• Be 18 years of age or older
•
Suffer from acute migraine headaches
•
Be in stable medical health
•
Reads and understands English
Qualified Participants May Receive:
- Study-related evaluation
- Diagnostic & laboratory evaluations
- Investigational drug or placebo
- Reimbursement for time and travel